Artiva Biotherapeutics, Inc (ARTV) insider trading
Every open-market stock purchase and sale by Artiva Biotherapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Ra Capital Management L.p. (Insider) bought $413K in the last 90 days.
- Fred Aslan (CEO) and 3 others sold $1.9M in the last 90 days.
Last 12 months: insiders bought $134M (10 buys) and sold $2.4M (18 sales). Last close $6.49 on Oct 21, 2026.
Recent ARTV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 6, 2026 | Fred Aslan (CEO) | Sold | $169K |
| Oct 5, 2026 | Fred Aslan (CEO) | Sold | $422K |
| Oct 5, 2026 | Christopher Horan (CTO) | Sold | $70.7K |
| Oct 5, 2026 | Jennifer Bush (COO) | Sold | $57.2K |
| Oct 5, 2026 | Subhashis Banerjee (C-suite exec) | Sold | $7.5K |
| Sep 15, 2026 | Fred Aslan (CEO) | Bought (not open market) | — |
| Sep 15, 2026 | Fred Aslan (CEO) | Bought (not open market) | — |
| Sep 10, 2026 | Brian Daniels (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Alison Moore (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Daniel G. Baker (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Fred Aslan (CEO) | Bought (not open market) | — |
| Sep 10, 2026 | Fred Aslan (CEO) | Bought (not open market) | — |
| Sep 10, 2026 | Laura Stoppel (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Elaine K. Sorg (Insider) | Bought (not open market) | — |
| Sep 10, 2026 | Elizabeth L Hougen (Insider) | Bought (not open market) | — |
| Sep 9, 2026 | Gines Diego Miralles (President) | Bought (not open market) | — |
| Sep 9, 2026 | Gines Diego Miralles (President) | Bought (not open market) | — |
| Sep 9, 2026 | Christopher Horan (CTO) | Bought (not open market) | — |
| Sep 9, 2026 | Christopher Horan (CTO) | Bought (not open market) | — |
| Sep 9, 2026 | Jennifer Bush (COO) | Bought (not open market) | — |
| Sep 9, 2026 | Jennifer Bush (COO) | Bought (not open market) | — |
| Sep 9, 2026 | Subhashis Banerjee (C-suite exec) | Bought (not open market) | — |
| Sep 9, 2026 | Subhashis Banerjee (C-suite exec) | Bought (not open market) | — |
| Sep 8, 2026 | Fred Aslan (CEO) | Sold | $256K |
Who's trading ARTV
- Fred Aslan, CEO: sold $1.8M (7 sales), last Oct 6, 2026
- Subhashis Banerjee, C-suite exec: sold $88.3K (4 sales), last Oct 5, 2026
- Christopher Horan, CTO: sold $249K (3 sales), last Oct 5, 2026
- Jennifer Bush, COO: sold $230K (3 sales), last Oct 5, 2026
- Elizabeth L Hougen, Insider: other filings, last Sep 10, 2026
- Elaine K. Sorg, Insider: other filings, last Sep 10, 2026
- Laura Stoppel, Insider: other filings, last Sep 10, 2026
- Daniel G. Baker, Insider: other filings, last Sep 10, 2026
- Brian Daniels, Insider: other filings, last Sep 10, 2026
- Alison Moore, Insider: other filings, last Sep 10, 2026
- Ra Capital Management L.p., Insider: bought $117M (19 buys), last Sep 10, 2026
- Gines Diego Miralles, President: other filings, last Sep 9, 2026
- Heather Raymon, VP: sold $27.9K (1 sale), last May 19, 2026
- GC Corp., Insider: bought $16.5M (2 buys), last May 11, 2026
- Thad Allen Huston, CFO: other filings, last Mar 10, 2026
Get free alerts when an insider at Artiva Biotherapeutics, Inc files a new trade →